The Bluntness Interview

Imagine you have a terminal illness.

You hear how a psilocybin session could help you make peace with death so that you can perhaps enjoy your remaining days on Earth.

There’s even a new law in your state called ‘Right to Try’ that gives terminal patients the ability to try experimental or restricted substances.

But then a DEA bureaucrat says no. Sorry. You can’t use psilocybin. Our hands are tied on this.

This has actually happened in Washington State, and now there is a widely supported lawsuit against the DEA.

https://www.thebluntness.com/posts/right-to-try-inside-the-psilocybin-lawsuit-against-the-dea

Latest Blog Posts

Watch now: Psychedelics and Grief: When Containment Stops Working 

Watch now: Psychedelics and Grief: When Containment Stops Working 

Supporting women in the wild with science and wisdom about psychedelics. 134. Psychedelics and Grief: When Containment Stops Working Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29 Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of ...

Read More
Breakthrough Therapeutics in Complex Illness

Breakthrough Therapeutics in Complex Illness

How Academy Members Are Integrating Psychedelics to Ease Distress Dr. Sunil Aggarwal is quoted in the feature story in the 2026 Fall Quarterly Newsletter from the American Academy of Hospice and Palliative Medicine. For patients facing serious illness, some of the deepest suffering cannot be measured on a numerical scale.  Some patients experience anxiety that does not respond to conventional treatment, as well as a deep sense of demoralization, isolation, and loss of meaning. Palliative and hospice care have long recognized treatment of this existential distress as central to whole-person care. Now, an emerging field of research is asking whether ...

Read More
Psychedelic science update & harm reduction training for naturopathic physicians

Psychedelic science update & harm reduction training for naturopathic physicians

8 CONTINUING EDUCATION (CE) HOURS FEBRUARY 1–4, 2027OPIHIHALE ETHNOBOTANICAL PRESERVEBig Island, Hawai‘i $2,850 INCLUDES Three nights lodging | All mealsGround transportation to and from Kona AirportCourse materials | Guided ethnobotanical tour AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve WHY THIS COURSE? As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines. Presented by the AIMS Institute in ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us